CLINICAL_TRIALS
ClinicalTrials.gov record update
Ganglioside-Monosialic Acid Prophylaxis for Cognitive Dysfunction Related to Whole Brain Radiotherapy in Breast Cancer Patients With Brain Metastases ，a Multi-center，Randomized，Single Blind，Phase III Clinical Trail
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT04395339
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:26:20.178254+00:00
- Published At
- 2024-08-01T00:00:00+00:00
- Record Updated At
- 2024-08-01
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Brain Metastases", "Radiotherapy Side Effect", "Cognitive Impairment", "Gangliosidosis, GM1", "Breast Cancer"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-08-01"- protocolSection.identificationModule.nctId
"NCT04395339"- protocolSection.identificationModule.officialTitle
"Ganglioside-Monosialic Acid Prophylaxis for Cognitive Dysfunction Related to Whole Brain Radiotherapy in Breast Cancer Patients With Brain Metastases \uff0ca Multi-center\uff0cRandomized\uff0cSingle Blind\uff0cPhase III Clinical Trail"- protocolSection.statusModule.overallStatus
"TERMINATED"- protocolSection.designModule.phases
["PHASE3"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.